bionomics’ acquisition of iliad chemicals

  1. 1,388 Posts.
    lightbulb Created with Sketch. 67
    ASX ANNOUNCEMENT
    25 May 2005

    BIONOMICS’ ACQUISITION OF ILIAD CHEMICALS

    • Acquisition of Iliad Chemicals to deliver advanced lead drug candidates in Bionomics’ focus areas of central nervous system (CNS) disorders and cancer.
    • Integration of Bionomics’ biological expertise with Iliad’s proprietary chemistry platform and chemistry team.
    • Key plank in Bionomics’ accelerated development strategy.
    • Iliad Chemicals acquired for 40.9 million Bionomics shares, with potential milestone payment of a further 13.6 million shares.
    • Bionomics completes A$6 million capital raising supported by Iliad shareholders.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.